[HTML][HTML] Review of the neurological benefits of phytocannabinoids

J Maroon, J Bost - Surgical neurology international, 2018 - ncbi.nlm.nih.gov
Background: Numerous physical, psychological, and emotional benefits have been
attributed to marijuana since its first reported use in 2,600 BC in a Chinese pharmacopoeia …

[HTML][HTML] Medical marijuana: clearing away the smoke

I Grant, JH Atkinson, B Gouaux… - The open neurology …, 2012 - ncbi.nlm.nih.gov
Recent advances in understanding of the mode of action of tetrahydrocannabinol and
related cannabinoid in-gredients of marijuana, plus the accumulating anecdotal reports on …

Clinical uses of cannabis and cannabinoids in the United States

EA Levinsohn, KP Hill - Journal of the neurological sciences, 2020 - Elsevier
The role of cannabis in medicine is rapidly evolving. Medical cannabis is now legal in a
majority of states, and THC and CBD, the prominent cannabinoids found in cannabis, have …

The therapeutic potential of the cannabinoids in neuroprotection

RI Grundy - Expert opinion on investigational drugs, 2002 - Taylor & Francis
After thousands of years of interest the last few decades have seen a huge increase in our
knowledge of the cannabinoids and their mode of action. Their potential as medical …

Pharmacology of medical cannabis

MR Amin, DW Ali - Recent advances in cannabinoid physiology and …, 2019 - Springer
The Cannabis plant has been used for many of years as a medicinal agent in the relief of
pain and seizures. It contains approximately 540 natural compounds including more than …

The case for medical marijuana in epilepsy

E Maa, P Figi - Epilepsia, 2014 - Wiley Online Library
Charlotte, a little girl with SCN 1 A‐confirmed D ravet syndrome, was recently featured in a
special that aired on CNN. Through exhaustive personal research and assistance from a C …

Phytocannabinoids in neurological diseases: could they restore a physiological GABAergic transmission?

P Cifelli, G Ruffolo, E De Felice, V Alfano… - International journal of …, 2020 - mdpi.com
γ-Aminobutyric acid type A receptors (GABAARs) are the main inhibitory mediators in the
central nervous system (CNS). GABAARs are pentameric ligand gated ion channels, and the …

Cannabinoids in health and disease

NM Kogan, R Mechoulam - Dialogues in clinical neuroscience, 2007 - Taylor & Francis
Cannabis sativa L. preparations have been used in medicine for millenia. However, concern
over the dangers of abuse led to the banning of the medicinal use of marijuana in most …

Therapeutic potential of cannabinoids in CNS disease

JL Croxford - CNS drugs, 2003 - Springer
The major psychoactive constituent of Cannabis sativa, Δ 9-tetrahydrocannabinol (Δ 9-THC),
and endogenous cannabinoid ligands, such as anandamide, signal through G-protein …

[HTML][HTML] Cannabinoids in neurodegenerative disorders and stroke/brain trauma: from preclinical models to clinical applications

J Fernández-Ruiz, MA Moro, J Martínez-Orgado - Neurotherapeutics, 2015 - Elsevier
Cannabinoids form a singular family of plant-derived compounds (phytocannabinoids),
endogenous signaling lipids (endocannabinoids), and synthetic derivatives with multiple …